2023-503945-78-00已完成1 期
Randomized, double-blind, placebo-controlled study assessing the safety, tolerability, pharmacokinetics and pharmacodynamics of pitolisant after repeated oral ascending doses for 14 days, including the pitolisant effect on cardiac repolarization in healthy volunteers.
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 入组人数
- 75
- 试验地点
- 1
研究概览
简要总结
暂无简介。
入排标准
- 年龄范围
- 18 years 至 64 years（18-64 Years）
- 性别
- Male
- 接受健康志愿者
- 是
入选标准
- 未提供
排除标准
- 未提供
研究者
Clinical Development Director
Scientific
Bioprojet Pharma
研究点 (1)
Loading locations...
相似试验
进行中（未招募）
不适用
Prospective clinical study, where patients are receiving or the study drug or an inactive drug called placebo wihtout knowing which of the two drugs is taken, even the Investigator is aware of the therapy taken by the patients. Patients are assigned to a specific treatment according to a randomization list. The study is performed to assess the effects and tolerability of K(D)PT in ulcerative colitis.mild to moderate ulcerative colitisMedDRA version: 14.1Level: SOCClassification code 10017947Term: Gastrointestinal disordersSystem Organ Class: 10017947 - Gastrointestinal disordersEUCTR2011-002462-20-ITDR. AUGUST WOLFF GMBH & CO. KG160
进行中（未招募）
不适用
Clinical trial to evaluate the efficacy and safety of K(D)PT in patients with mild to moderate ulcerative colitisEUCTR2011-002462-20-PLDr August Wolff GmbH & Co KG Arzneimittel160
进行中（未招募）
不适用
Clinical trial to evaluate the efficacy and safety of K(D)PT in patients with mild to moderate ulcerative colitisEUCTR2011-002462-20-HUDr August Wolff GmbH & Co KG Arzneimittel
进行中（未招募）
不适用
Clinical trial to evaluate the efficacy and safety of K(D)PT in patients with mild to moderate ulcerative colitisAcute mild to moderate ulcerative colitis.MedDRA version: 14.1Level: LLTClassification code 10066678Term: Acute ulcerative colitisSystem Organ Class: 10017947 - Gastrointestinal disordersEUCTR2011-002462-20-SKDr August Wolff GmbH & Co KG Arzneimittel
进行中（未招募）
不适用
Clinical trial to evaluate the efficacy and safety of K(D)PT in patients with mild to moderate ulcerative colitisAcute mild to moderate ulcerative colitis.MedDRA version: 14.1Level: LLTClassification code 10066678Term: Acute ulcerative colitisSystem Organ Class: 100000004856EUCTR2011-002462-20-CZDr August Wolff GmbH & Co KG Arzneimittel